THE PILL THAT MOVES THE NEEDLE

Serial Number 97072349
Registration 7599887
700

Registration Progress

Application Filed
Oct 13, 2021
Under Examination
Jan 17, 2023
Approved for Publication
Nov 22, 2022
Published for Opposition
Nov 22, 2022
Registered
Dec 10, 2024

Trademark Image

THE PILL THAT MOVES THE NEEDLE

Basic Information

Serial Number
97072349
Registration Number
7599887
Filing Date
October 13, 2021
Registration Date
December 10, 2024
Published for Opposition
November 22, 2022
Drawing Code
4

Status Summary

Current Status
Active
Status Code
700
Status Date
Dec 10, 2024
Registration
Registered
Classes
042

Rights Holder

Vaxart, Inc.

03
Address
170 Harbor Way, Suite 300
South San Francisco, CA 94080

Ownership History

Vaxart, Inc.

Original Applicant
03
South San Francisco, CA

Vaxart, Inc.

Owner at Publication
03
South San Francisco, CA

Vaxart, Inc.

Original Registrant
03
South San Francisco, CA

Legal Representation

Attorney
Roger H. Bora

USPTO Deadlines

Next Deadline
1803 days remaining
Section 8 Declaration Due (Principal Register) (Based on registration date 20241210)
Due Date
December 10, 2030
Grace Period Ends
June 10, 2031
Additional deadlines exist. Contact your attorney for complete deadline information.

Application History

30 events
Date Code Type Description Documents
Dec 10, 2024 NRCC E NOTICE OF REGISTRATION CONFIRMATION EMAILED Loading...
Dec 10, 2024 R.PR A REGISTERED-PRINCIPAL REGISTER Loading...
Nov 18, 2024 SUNA E NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED Loading...
Nov 18, 2024 CNPR P ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED Loading...
Oct 16, 2024 SUPC I STATEMENT OF USE PROCESSING COMPLETE Loading...
Jan 5, 2024 IUAF S USE AMENDMENT FILED Loading...
Jan 24, 2024 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Jan 23, 2024 EX2G S SOU EXTENSION 2 GRANTED Loading...
Jan 5, 2024 EXT2 S SOU EXTENSION 2 FILED Loading...
Jan 23, 2024 AITU A CASE ASSIGNED TO INTENT TO USE PARALEGAL Loading...
Jan 5, 2024 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Jan 5, 2024 EISU I TEAS STATEMENT OF USE RECEIVED Loading...
Jul 4, 2023 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Jun 30, 2023 EX1G S SOU EXTENSION 1 GRANTED Loading...
Jun 30, 2023 EXT1 S SOU EXTENSION 1 FILED Loading...
Jun 30, 2023 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Jan 17, 2023 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
Nov 22, 2022 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Nov 22, 2022 PUBO A PUBLISHED FOR OPPOSITION Loading...
Nov 2, 2022 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Oct 18, 2022 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Oct 14, 2022 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Oct 14, 2022 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Oct 14, 2022 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Jul 26, 2022 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
Jul 26, 2022 GNRT F NON-FINAL ACTION E-MAILED Loading...
Jul 26, 2022 CNRT R NON-FINAL ACTION WRITTEN Loading...
Jul 19, 2022 DOCK D ASSIGNED TO EXAMINER Loading...
Nov 3, 2021 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Oct 16, 2021 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 042
Research and development of vaccines; vaccine research and development, namely, vaccine formulation services; research and laboratory testing of the formulation of vaccines; scientific research in the nature of clinical trials and research in the field of vaccines; and providing reports for all of the foregoing
First Use Anywhere: 20210900
First Use in Commerce: 20210900

Classification

International Classes
042